key: cord-0958913-tfb1ve2p
authors: Magro, Cynthia; Mulvey, J. Justin; Berlin, David; Nuovo, Gerard; Salvatore, Steven; Harp, Joanna; Baxter-Stoltzfus, Amelia; Laurence, Jeffrey
title: Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases
date: 2020-04-15
journal: Transl Res
DOI: 10.1016/j.trsl.2020.04.007
sha: e5cbf870581f4c0bba40c496623aa733281e82c8
doc_id: 958913
cord_uid: tfb1ve2p

Abstract Acute respiratory failure and a systemic coagulopathy are critical aspects of the morbidity and mortality characterizing infection with severe acute respiratory distress syndrome-associated coronavirus-2 (SARS-CoV-2), the etiologic agent of Coronavirus disease 2019 (COVID-19). We examined skin and lung tissues from 5 patients with severe COVID-19 characterized by respiratory failure (n=5) and purpuric skin rash (n=3). The pattern of COVID-19 pneumonitis was predominantly a pauci-inflammatory septal capillary injury with significant septal capillary mural and luminal fibrin deposition and permeation of the inter-alveolar septa by neutrophils. No viral cytopathic changes were observed and the diffuse alveolar damage (DAD) with hyaline membranes, inflammation, and type II pneumocyte hyperplasia, hallmarks of classic ARDS, were not prominent. These pulmonary findings were accompanied by significant deposits of terminal complement components C5b-9 (membrane attack complex), C4d, and mannose binding lectin (MBL)-associated serine protease (MASP)2, in the microvasculature, consistent with sustained, systemic activation of the alternative and lectin-based complement pathways. The purpuric skin lesions similarly showed a pauci-inflammatory thrombogenic vasculopathy, with deposition of C5b-9 and C4d in both grossly involved and normally-appearing skin. In addition, there was co-localization of COVID-19 spike glycoproteins with C4d and C5b-9 in the inter-alveolar septa and the cutaneous microvasculature of two cases examined. In conclusion, at least a subset of sustained, severe COVID-19 may define a type of catastrophic microvascular injury syndrome mediated by activation of complement pathways and an associated procoagulant state. It provides a foundation for further exploration of the pathophysiologic importance of complement in COVID-19, and could suggest targets for specific intervention.

The severe acute respiratory distress syndrome-associated coronavirus-2 (SARS-CoV-2), etiologic agent of Coronavirus disease 2019 (COVID- 19) , was initially identified in Wuhan, Hubei, China in December 2019 (1) . It was documented to be pandemic by the World Health Organization in early March 2020 (2) , and by early April there were over 1.5 million cases worldwide, with over 90,000 deaths (3). Organ dysfunction, particularly progressive respiratory failure and a generalized coagulopathy, are associated with the highest mortality (1, 4, 5) .

It was soon recognized that SARS-CoV-2 is but one of a large pool of pre-pandemic SARS-like bat coronaviruses which replicate in primary human airway epithelial cells, using human Angiotensin Converting Enzyme (ACE)2 entry receptors (6) . These include the etiologic agents of the original SARS-CoV and Middle East respiratory syndrome (MERS)-CoV, for which mortality is also linked to severe respiratory failure, with pathologic evidence of ARDS (7) . Preliminary pathology studies of COVID-19 patients demonstrated diffuse alveolar damage (DAD) with edema, hyaline membranes, and inflammation, followed by type II pneumocyte hyperplasia, features characteristic of typical ARDS (8, 9) . But many patients with COVID-19related severe respiratory distress have a delayed onset of respiratory distress (10) , then manifest relatively well-preserved lung mechanics, despite the severity of hypoxemia, characterized by high respiratory compliance and high shunt fraction, and prolonged requirement for mechanical ventilation (10, 11) . Therefore, significant aspects of the pathology of COVID-19 might be expected to differ from classic ARDS.

We examined lung and cutaneous tissues from 5 patients with SARS-CoV-2 infection and severe respiratory failure, 3 of whom also had features consistent with a systemic procoagulant state, including retiform purpura or livedo racemosa-prominent dermatologic signs of a generalized microvascular thrombotic disorder-and markedly elevated d-dimers.

Histologic and immunohistochemistry studies defined a pattern of cutaneous and pulmonary pathology involving microvascular injury and thrombosis, consistent with activation of the alternative pathway (AP) and lectin pathway (LP) of complement. Co-localization of SARS-CoV-2-specific spike glycoproteins with complement components in the lung and skin was also documented. Our studies suggest that at least a subset of severe COVID-19 infection involves a catastrophic, complement-mediated thrombotic microvascular injury syndrome with sustained activation of the AP and LP cascades. Potential mechanisms of complement activation, including involvement of positive feedback loops with the coagulation system, are discussed in the context of hypothesis-generating studies providing the foundation for potential therapeutic intervention.

Patient population: All five patients were selected for pathologic studies based on a respiratory tract sample positive for SARS-CoV-2 in a reverse transcriptase-polymerase chain reaction assay, as tested by a designated diagnostic laboratory. They represent the first two patients succumbing to COVID-19 and undergoing autopsy that were available to us, and the first three infected individuals for whom a dermatologic consult had been requested to evaluate an extensive skin rash. These five cases were assembled over a period of two weeks. A respiratory pathogen PCR panel was used to test for other potential pulmonary viral pathogens, along with standard bacterial and fungal respiratory cultures, and these tests were unrevealing. Cases 2, 3 and 4 received hydroxychloroquine and/or azithromycin, as noted, with dosing as: hydroxychloroquine, 600mg every 12 hours for one day then 400mg every 12 hours for 4 days; azithromycin: 500mg daily for 5 days .

Routine light microscopy and immunohistochemical (IHC) assessment for the deposition of C5b-9 (membrane attack complex, MAC), C3d, and C4d via a diaminobenzidene (DAB) technique was conducted. Identification of C5b-9, C3d, or C4d within any epithelial basement membrane zone, elastic fibers, or the elastic lamina of vessels was considered nonspecific staining. IHC was performed using C3d (Cell Marque, Rocklin CA, 403A-78), C4d (Alpco, Salem NH, BI-RC4d), C5b-9 (Agilent, Santa Clara CA, M077701-5), and MASP2 (Sigma, St. Louis, MO, HPA029313) antibodies on paraffin embedded sections using a modified Leica protocol. Heat mediated antigen retrieval with Tris-EDTA buffer (pH = 9, epitope retrieval solution 2) was performed for 20 min, followed by incubation with each antibody for 15 min. Details have been described by one of the authors, including documentation of the involvement of many of these complement components in pathologic processes linked to complement activation in both dermal and lung tissues (12) (13) (14) (15) .

Staining for SARS-CoV-2 spike (catalogue #3525) and envelope (catalogue #3531) proteins (Prosci, Poway, CA) was optimized with cells from nasopharyngeal preparations obtained from individuals known to be positive or negative for the virus before being employed in the current studies. It involves use of horseradish peroxidase conjugate (ENZO, catalogue #ADI-950-113-0100) and an HRP-conjugated compact polymer system, with DAB as chromogen. Hematoxylin and eosin counterstain was used and mounted with Leica Micromount.

A 62 year-old male with a history of coronary artery disease, diabetes mellitus, heart failure with preserved ejection fraction, prior treatment for hepatitis C virus infection, and endstage renal disease on intermittent hemodialysis was evaluated in an emergency department x-ray demonstrated bilateral airspace opacities most prominent in the peri-hilar distribution.

After discussion with his family, he was placed on comfort measures and died a few hours after presentation. A limited autopsy was performed. Grossly, the lungs had a congested and hemorrhagic appearance. Light microscopic examination revealed a severe organizing hemorrhagic pneumonitis (Fig. 1A) , including significant fibrin deposition within septal capillary lumens and walls accompanied by endothelial cell necrosis, consistent with a thrombotic necrotizing capillary injury syndrome (Fig. 1B) . The pattern of septal capillary injury ranged from a pauci-inflammatory pattern (Fig. 1C) to one characterized by permeation of the interalveolar septa by neutrophils amidst the damaged capillaries, along with intra-alveolar neutrophils (Fig. 1D) . No viral cytopathic changes were observed. Hyaline membranes reflective of DAD were not observed. In addition, and in contrast to preliminary reports of COVID-19 lung pathology (8, 9) , type II pneumocyte hyperplasia was not appreciated ( Fig. 1A-D) . The brunt of the lung injury was restricted to septal capillaries, without pneumocyte involvement.

Extensive C4d deposition localized to the inter-alveolar septal capillaries was then demonstrated ( Fig. 2A,B ). C5b-9 deposition was also seen, showing a similar pattern of septal capillary localization as for C4d, although reduced in intensity (Fig. 2C ). Granular deposition of C3d was also noted; although minimal in comparison to the C5b-9 and C4d deposits, it expressed a similar pattern of septal capillary localization (Fig. 2D ). MASP2 staining was attempted but, due to high background staining in this case, was deemed technically unsatisfactory.

In order to explore possible generalized complement activation in this patient, a sample of clinically-appearing normal skin was also found to have significant vascular deposits of C5b-9 within dermal capillaries (not shown).

A 73 year-old male with a history of smoking, obesity, and pre-diabetes developed respiratory distress and was evaluated in the ED. He was febrile, tachypneic, severely hypoxemic, and required emergent endotracheal intubation. He had a serum creatinine of 2.4. ventilator support for one week, which can itself lead to some DAD, and yet, as in Case 1, the dominant pattern was septal capillary injury, not DAD.

On IHC there was prominent deposition of C5b-9 within the microvasculature of the inter-alveolar septa as well as in larger caliber vessels of the lung parenchyma ( Fig. 4A ,B). Of interest, C5b-9 septal deposition was not limited to areas of diseased lung, but was also seen in normal-appearing lung and tracheal soft tissues, while C4d was localized to inter-alveolar septa in regions of microvascular injury (Fig. 4C After only 4 days on ventilator support, retiform purpura with extensive surrounding inflammation was noted on his buttocks (Fig. 5A) . Skin biopsy showed a striking thrombogenic vasculopathy accompanied by extensive necrosis of the epidermis and adnexal structures, including the eccrine coil. There was a significant degree of interstitial and perivascular neutrophilia with prominent leukocytoclasia (Fig. 5B ). IHC showed striking and extensive deposition of C5b-9 within the microvasculature (Fig. 5C ).

A 66 year-old female, with no significant past medical history, was brought to the ED after 9 days of fever, cough, diarrhea, and chest pain. She was hypoxemic, with diffuse bilateral patchy airspace opacities, without effusions, on chest x-ray. She was admitted and treated with hydroxychloroquine and prophylactic anticoagulation with enoxaparin. Three days later she became confused, increasingly hypoxemic with rising serum creatinines, and was intubated.

Renal replacement was initiated. On hospital day 10, thrombocytopenia (platelets 128 x 10 9 /L) and a markedly elevated d-dimer of 7030ng/ml, but normal INR and PTT, were noted. The next day dusky purpuric patches appeared on her palms and soles bilaterally (Fig. 6A) . A skin biopsy of one lesion showed superficial vascular ectasia and an occlusive arterial thrombus within the deeper reticular dermis in the absence of inflammation (Fig. 6B) . Extensive vascular deposits of C5b-9 (Fig. 6C) , C3d, and C4d (Fig. 6D) were observed throughout the dermis, with marked deposition in an occluded artery. A biopsy of normal-appearing deltoid skin also showed conspicuous microvascular deposits of C5b-9 (Fig. 6E ). Sedative infusions were discontinued that day, unmasking a comatose state. Computerized tomographic imaging of the head revealed multifocal supra-and infra-tentorial infarctions, with complete infarction of the area supplied by the left middle cerebral artery.

A 40 year-old female, with no significant past medical history, presented to the ED after 2 weeks of dry cough, fever, myalgias, diarrhea, and progressive dyspnea. She had been diagnosed one week earlier, at an outside hospital, with COVID-19. Electrocardiogram revealed severely reduced left ventricular function. Patchy bilateral airspace opacities were noted and she was soon intubated for respiratory failure and shock. D-dimer was elevated at 1187ng/ml, with a normal platelet count and PTT, but an elevated INR of 1.4. Mildly purpuric reticulated eruptions on her chest, legs and arms, consistent with livedo racemosa, were noted (Fig. 7A) , and a skin biopsy performed. There was a modest perivascular lymphocytic infiltrate in the superficial dermis along with deeper seated small thrombi within rare venules of the deep dermis, in the absence of a clear vasculitis (Fig. 7B ). Significant vascular deposits of C5b-9 (Fig. 7C) and C4d

( Fig. 7D) were observed. As for Case 4, a biopsy of normal deltoid skin showed microvascular deposits of C5b-9 throughout the dermis (Fig. 7E ).

SARS-CoV-2 spike and envelope proteins strongly localized to the respiratory epithelia and the inter-alveolar septa in tissue from Case 1. No signal was found in control lung samples (data not shown). Using NUANCE software, by which the fluorescent signal tagging CoV proteins appears red and the DAB chromogen tagging C4d appears green, a merged image shows a strong yellow signal indicative of septal capillary C4d and SARS-CoV-2 co-localization ( Fig. 8A-D) . A similar analysis in which the DAB chromogen was used to tag C5b-9 also gave a merged image with a strong yellow signal, indicative of septal vascular C5b-9 co-deposition with SARS-CoV-2 protein (Fig. 8E-H) . In terms of the skin, co-localization of C4d with SARS-CoV-2 glycoprotein was demonstrated for Case 2 (Fig. 9A,B ).

Using pulmonary and cutaneous biopsy and autopsy samples from five individuals with severe COVID-19 we document that at least some SARS-CoV-2-infected patients who become critically ill suffer a generalized thrombotic microvascular injury. Such pathology involves at least the lung and skin, and appears mediated by intense complement activation. Specifically, we found striking septal capillary injury accompanied by extensive deposits of the terminal complement complex C5b-9 as well as C4d and MASP2 in the lungs of two cases examined, and a similar pattern of pauci-inflammatory complement mediated microthrombotic disease in the skin of three cases with retiform and purpuric lesions, with C5b-9 and C4d deposition in samples taken from both cutaneous lesions and normal-appearing skin.

Our histologic findings are consistent with emerging observations suggesting that COVID-19 has clinical features distinct from typical ARDS. That is, COVID-19-related severe respiratory distress can be manifest by relatively well-preserved lung mechanics, despite the severity of hypoxemia, characterized by high respiratory compliance, high shunt fraction, and prolonged requirement for mechanical ventilation (10, 11) . The pathology in these cases might therefore be expected to differ from the diffuse alveolar damage and hyaline membrane formation which are hallmarks of typical ARDS. Albeit preliminary pathology studies of lungs from COVID-19 cases described DAD with edema, hyaline membranes, and inflammation, followed by type II pneumocyte hyperplasia, features characteristic of typical ARDS (8, 9) , the pulmonary abnormalities in our patients appear largely restricted to the alveolar capillaries, i.e., more of a thrombotic microvascular injury with few signs of viral cytopathic or fibroproliferative

changes. An increase in the dead space fraction might be anticipated with this type of pathology,

i.e., respiratory failure accompanied by greater lung compliance and less pulmonary consolidation than is characteristic of typical ARDS. Indeed, the histologic pattern of paucicellular terminal lung parenchymal injury with septal capillary damage we document resembles images captured in early case reports in the Chinese language literature of severe COVID-19

pneumonitis (16).

We now show that this pathologic pattern, atypical for classic ARDS, is accompanied by extensive deposition of AP and LP complement components within the lung septal microvasculature. With such extensive complement involvement, membrane attack complexmediated microvascular endothelial cell injury and subsequent activation of the clotting pathway, leading to fibrin deposition, might be anticipated (17), as observed in our cases. It is also consistent with the very high d-dimer levels found in the three cases in which it was assessed.

Vascular deposition of C5b-9 is a key feature of many microthrombotic syndromes, regardless of the particular syndromic complex, including catastrophic antiphospholipid antibody syndrome, atypical hemolytic uremic syndrome, purpura fulminans and severe multi-organ malignant atrophic papulosis, and they may respond to anti-complement therapies (18) (19) (20) (21) (22) (23) .

A pre-clinical model of SARS infection emphasizes the potential role of complement in the parenchymal lung injury of coronavirus infection (7) . Mouse-adapted SARS-CoV MA15

infection of C3 -/mice led to significantly less weight loss and respiratory dysfunction than seen in wild-type mice, and this occurred despite equivalent viral loads in the lung (7). Another feature reflective of a prominence of complement-mediated pathology rather than simply inflammation or vasculitis in our COVID-19 patients was the extent of septal and intra-alveolar neutrophilia. It was present, but pauci-inflammatory. SARS-CoV-infected wild-type mice also had higher levels of neutrophils in the lung than their C3 -/counterparts (7). Tissue neutrophilia may be attributable to the neutrophil chemoattractant properties of complement. Both neutrophils and complement are key sentinels of innate immunity and also modulate thrombogenic pathways, the latter thought related to C5a receptor/tissue factor cross-talk mediated by neutrophils (24) . Neutrophilia in human SARS-CoV patients is associated with a poor outcome and could be an index of the extent of complement activation (7, 25) . Peripheral neutrophilia is not a significant observation in limited series of COVID-19 patients from China (26) There may also be pathways apart from virus spike engagement by which LP and AP are activated. First, MBL and ficolins bind to pathogen-associated molecular patterns present on injured cells, enabling complex formation with MASP2 (36) . In addition, all three ARDS-linked coronaviruses use ACE2 as an entry point to cells (6) . Angiotensin I and angiotensin II have been associated with inflammation, oxidative stress, and fibrosis, and ACE2 is involved in their deactivation (37) . If overwhelming coronavirus infection, with binding to ACE2 on epithelial targets not only in the lung but in other tissues expressing these proteins, including the kidney, intestines, and brain, were to interfere with ACE2 activity, the resulting increases in angiotensin II could lead to reactive oxygen species formation and interference with anti-oxidant and vasodilatory signals such as NOX2 and eNOS, with further complement activation. This has been demonstrated in a rat model of angiotensin II over-expression linked to other disorders (38) .

The potential loss of auto-vasoconstriction and regulation of lung blood flow through injured vascular segments would also lead to increased shunting and severe hypoxemia. Fig. 10 summarizes the potential mechanisms of SARS-CoV2 associated complement activation, and its possible interaction with coagulation pathways.

Given these data, use of agents that block LP activation at MBL recognition domains, shows a significant degree of C4d and SARS-CoV2 co-localization, as revealed by intense yellow staining. E-H: A similar pattern was observed using an anti-C5b-9 reagent whose image appears green, with a significant degree of C5b-9 and SARS-CoV2 co-localization, as revealed by intense yellow staining. 

A novel coronavirus from patients with pneumonia in China

WHO Declares COVID-19 a Pandemic

Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan

Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia

Novel coronavirus: From discovery to clinical diagnostics

Complement activation contributes to severe acute respiratory syndrome coronavirus pathogenesis. mBio

Pathologic findings of COVID-19 associated with acute respiratory distress syndrome

Histopathologic changes and SARS-Cov-2 immunostaining in the lung of a patient with COVID-19

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Covid-19 Does Not Lead to a "Typical" Acute Respiratory Distress Syndrome

Degos disease: a C5b-9/interferon-α-mediated endotheliopathy syndrome

The role of the skin biopsy in the diagnosis of atypical hemolytic uremic syndrome

Use of C4d as a diagnostic adjunct in lung allograft biopsies

Humorally mediated posttransplantation septal capillary injury syndrome as a common form of pulmonary allograft rejection: a hypothesis

Complement activity and complement regulatory gene mutations are associated with thrombosis in APS and CAPS

Degos disease: A C5b-9/interferon-α-mediated endotheliopathy syndrome

Insights into the pathogenesis of catastrophic antiphospholipid syndrome. A case report of relapsing catastrophic antiphospholipid syndrome and review of the literature on ischemic colitis

Typical and Atypical Hemolytic Uremic Syndrome in the Critically Ill

Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults

The effects of Eculizumab on the pathology of malignant atrophic papulosis

Anovel C5a receptor-tissue factor cross-talk in neutrophils links innate immunity to coagulation pathways

Modeling the early events of severe acute respiratory syndrome coronavirus infection in vitro

Hematologic parameters in patients with COVID-19 infection

Covid-19 in critically ill patients in the Seattle region--case series

An approach to the patient with retiform purpura

Atypical hemolytic uremic syndrome (aHUS): essential aspects of an accurate diagnosis

Terminal complement complex (C5b-9) in children with recurrent hemolytic uremic syndrome

Complement activity and complement regulatory gene mutations are associated with thrombosis in APS and CAPS

A single asparagine-linked glycosylation site of the severe acute respiratory syndrome coronavirus spike glycoprotein facilitates inhibition by mannose-binding lectin through multiple mechanisms

The lectin pathway of complement and rheumatic heart disease

Simultaneous activation of complement and coagulation by MBL-associated serine protease 2

Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein

Be on target: strategies of targeting alternative and lectin pathway components in complement-mediated diseases

Imbalance between Angiotensin II -Angiotensin (1-7) system is associated with vascular endothelial dysfunction and inflammation in type 2 diabetes with newly diagnosed hypertension

Complement activation in angiotensin IIinduced organ damage

Improved survival following OMS721 treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy (HCT-TMA)

Figure 6. Clinical, microscopic, and immunhohistochemical analyses of Case 4. A: Prominent livedo rashes on the palmar and plantar aspects of the hands and feet, respectively, were noted

C: Extensive endothelial and subendothelial deposits of C5b-9 are observed within the thrombosed artery. (Diaminobenzidene, 400x.) D: A similar striking pattern of endothelial and subendothelial C4d deposition is noted within the artery. (Diaminobenzidene, 400x.) E: A biopsy of normal-appearing deltoid skin showing conspicuous microvascular deposits of C5b-9

B: A skin biopsy revealed a few deep-seated venules at the dermal-subcuticular interface containing small fibrin thrombi. (Hematoxylin and eosin, 400x.) C: There are significant vascular deposits of C5b-9 within the dermis. (Diaminobenzidene, 400x.) D: Vascular deposits of C4d were also observed within the dermal microvasculature

The authors are aware of the journal's authorship statement and only Dr.